These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans. Brown P; Cervenáková L; McShane LM; Barber P; Rubenstein R; Drohan WN Transfusion; 1999; 39(11-12):1169-78. PubMed ID: 10604242 [TBL] [Abstract][Full Text] [Related]
26. Host genetic control of incubation periods of Creutzfeldt-Jakob disease in mice. Mohri S; Tateishi J J Gen Virol; 1989 Jun; 70 ( Pt 6)():1391-400. PubMed ID: 2659733 [TBL] [Abstract][Full Text] [Related]
27. The ultrastructural diversity of scrapie-associated fibrils isolated from experimental scrapie and Creutzfeldt-Jakob disease. Liberski PP; Brown P; Xiao SY; Gajdusek DC J Comp Pathol; 1991 Nov; 105(4):377-86. PubMed ID: 1770176 [TBL] [Abstract][Full Text] [Related]
28. Appearance of tubulovesicular structures in experimental Creutzfeldt-Jakob disease and scrapie precedes the onset of clinical disease. Liberski PP; Yanagihara R; Gibbs CJ; Gajdusek DC Acta Neuropathol; 1990; 79(4):349-54. PubMed ID: 2160182 [TBL] [Abstract][Full Text] [Related]
29. Practical methods for chemical inactivation of Creutzfeldt-Jakob disease pathogen. Tateishi J; Tashima T; Kitamoto T Microbiol Immunol; 1991; 35(2):163-6. PubMed ID: 1909414 [TBL] [Abstract][Full Text] [Related]
30. A simple and effective method for inactivating virus infectivity in formalin-fixed tissue samples from patients with Creutzfeldt-Jakob disease. Brown P; Wolff A; Gajdusek DC Neurology; 1990 Jun; 40(6):887-90. PubMed ID: 1693181 [TBL] [Abstract][Full Text] [Related]